Headquarters
3060 PEGASUS PARK DR, DALLAS, TX 75247-6204, US
DALLAS, TX, US
ADJUVANT GENOMICS, INC
From the company
Adjuvant Genomics provides genomic insights for non-small cell lung cancer (NSCLC) patients, empowering oncologists with a risk and treatment response score. The company identifies high-risk patients more likely to experience cancer recurrence, predicts responsiveness to adjuvant chemotherapy, and supports faster transition to alternative adjuvant therapies. It aims to improve prognosis and treatment outcomes for patients with Stage 1 & 2 NSCLC.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.